Biliary Liver Cirrhosis

FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.

Also Known As:

Primary Biliary Cirrhosis; Biliary Cirrhosis; Secondary Biliary Cirrhosis; Liver Cirrhosis, Biliary; Biliary Cirrhosis, Primary, 1; Secondary Biliary Cholangitis; Biliary Cholangitides, Primary; Biliary Cholangitis, Primary; Biliary Cholangitis, Secondary; Cholangitides, Primary Biliary; Cholangitis, Primary Biliary; Cholangitis, Secondary Biliary; Cirrhosis, Biliary; Cirrhosis, Secondary Biliary; Liver Cirrhoses, Biliary; Obstructive Liver Cirrhosis; Primary Biliary Cholangitides; Secondary Biliary Cholangitides; Biliary Cirrhosis, Primary; Biliary Cirrhosis, Secondary; Cholangitis, Chronic Nonsuppurative Destructive; Liver Cirrhosis, Obstructive; Primary Biliary Cholangitis

Digestive System Diseases: 1068
- Liver Diseases: 42767
  - Liver Cirrhosis: 27180
    - Biliary Liver Cirrhosis: 5086
  - Intrahepatic Cholestasis: 1078
    - Biliary Liver Cirrhosis: 5086
- Biliary Tract Diseases: 470
  - Bile Duct Diseases: 96
    - Cholestasis: 8057
      - Intrahepatic Cholestasis: 1078
        Biliary Liver Cirrhosis: 5086
Signs and Symptoms Pathological Conditions
- Pathologic Processes: 10385
  - Fibrosis: 103448
    - Liver Cirrhosis: 27180
      - Biliary Liver Cirrhosis: 5086

AESOP Study Investigators Selected Research

AESOP Study Investigators Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure